Pharmaceuticals Recalls Lamprene(r) Soft Gelatin Capsules
FOOD AND DRUG ADMINISTRATION
FOR IMMEDIATE RELEASE
Consumer Media: 888-Info-FDA
May 19, 1999
East Hanover, NJ (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Novartis Pharmaceuticals Corporation is recalling
Lamprene(r) Soft Gelatin Capsules (Clofazimine), 50 mg, in 100 capsule bottles, because of
Lamprene(r) Soft Gelatin
Capsules are a prescription used in the treatment of lepromatous leprosy.
Lot #1028700 EXP 9/98.
R.P. Scherer GMBH, Eberbach/Baden Germany.
Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, by fax on June 16, 1998,
followed by mail. Firm-initiated recall complete.
27,523 bottles were distributed.